Suven Pharmaceuticals' Stock Sees Dip, Remains Strong Player in Pharma Industry.

Suven Pharmaceuticals, a leading player in the pharmaceuticals and drugs industry, has recently seen a dip in its stock performance. On September 16, 2024, the company's stock lost -3.24%, underperforming the sector by -3.46%. This has led to a 'Hold' call by MarketsMOJO for the stock.

The stock's price summary shows that it has fallen after three consecutive days of gains, with an intraday low of Rs 1161.35 (-4.04%). However, the moving averages for Suven Pharmaceuticals are still higher than the 20 day, 50 day, 100 day, and 200 day moving averages, but lower than the 5 day moving average.

In comparison to the Sensex performance, Suven Pharmaceuticals' 1 day performance is -3.23%, while the Sensex has shown a positive performance of 0.12%. Similarly, the company's 1 month performance is 17.81%, while the Sensex has shown a growth of 3.17%.

Despite the recent dip in stock performance, Suven Pharmaceuticals remains a largecap company in the pharmaceuticals and drugs industry. With a strong presence in the market, the company continues to be a key player in the industry. Investors are advised to hold their positions and monitor the stock's performance in the coming days.